Income Statement Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:00:02 2025-12-12 EST			5-day change	1st Jan Change
100.30 ^USD	+1.30%		+0.58%	+0.82%

12-12	Merck Receives Positive EU Chmp Opinion for Expanded Use of Winrevair?? (Sotatercept) in Adults with Pulmonary Arterial Hypertension (Pah, Who* Group 1 Pulmonary Hypertension)	CI
12-12	Merck Says Europe's CHMP Grants 'Positive Opinion' for Winrevair Expansion for Pulminary Arterial Hypertension	MT

6818702a2b0b1.LOXmXFY5w0cYEmM1cDsFVyRApJk1mfE5A5ViULWYKW0.FNyvamZakBRvKhcMBghEIU9wkfIEqsNravRQAtPBRit-pqIVIVqOPkpmFA

Published financial data: MERCK & CO., INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	47.99B	48.7B	59.28B	60.12B	64.17B
Total Revenues	47.99B	48.7B	59.28B	60.12B	64.17B
Cost of Goods Sold, Total	13.42B	13.24B	17.21B	15.92B	14.7B
Gross Profit	34.57B	35.46B	42.08B	44.2B	49.47B
Selling General & Admin Expenses, Total	9.37B	9.4B	9.67B	9.88B	10.1B
R&D Expenses	10.31B	10.2B	11.84B	18.34B	14.48B
Other Operating Expenses, Total	19.68B	19.61B	21.51B	28.23B	24.58B
Operating Income	14.89B	15.86B	20.56B	15.97B	24.89B
Interest Expense, Total	-831M	-806M	-962M	-1.15B	-1.27B
Interest And Investment Income	59M	36M	314M	365M	415M
Net Interest Expenses	-772M	-770M	-648M	-781M	-856M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-145M	-297M	-237M	-370M	-227M
Other Non Operating Income (Expenses)	126M	256M	524M	420M	290M
EBT, Excl. Unusual Items	14.1B	15.05B	20.2B	15.24B	24.1B
Restructuring Charges	-883M	-868M	-666M	-933M	-888M
Merger & Related Restructuring Charges	-4.75B	-1.7B	-	-11.41B	-3.46B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	1.34B	1.94B	-1.42B	340M	14M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-90M	-275M	-1.6B	-779M	-
In Process R&D Expenses	-	-	-	-	-
Legal Settlements	-	-	-	-573M	-
Other Unusual Items	-920M	-260M	-75M	-	170M
EBT, Incl. Unusual Items	8.79B	13.88B	16.44B	1.89B	19.94B
Income Tax Expense	1.71B	1.52B	1.92B	1.51B	2.8B
Earnings From Continuing Operations	7.08B	12.36B	14.53B	377M	17.13B
Earnings Of Discontinued Operations	-	704M	-	-	-
Net Income to Company	7.08B	13.06B	14.53B	377M	17.13B
Minority Interest	-15M	-13M	-7M	-12M	-16M
Net Income - (IS)	7.07B	13.05B	14.52B	365M	17.12B
Net Income to Common Incl Extra Items	7.07B	13.05B	14.52B	365M	17.12B
Net Income to Common Excl. Extra Items	7.07B	12.34B	14.52B	365M	17.12B
Per Share Items
Net EPS - Basic	2.79	5.16	5.73	0.14	6.76
Basic EPS - Continuing Operations	2.79	4.88	5.73	0.14	6.76
Basic Weighted Average Shares Outstanding	2.53B	2.53B	2.53B	2.54B	2.53B
Net EPS - Diluted	2.78	5.14	5.71	0.14	6.74
Diluted EPS - Continuing Operations	2.78	4.86	5.71	0.14	6.74
Diluted Weighted Average Shares Outstanding	2.54B	2.54B	2.54B	2.55B	2.54B
Normalized Basic EPS	3.48	3.71	4.98	3.75	5.94
Normalized Diluted EPS	3.46	3.7	4.96	3.74	5.92
Dividend Per Share	2.44	2.6	2.76	2.92	3.08
Payout Ratio	87.94	50.66	48.3	2.04K	45.8
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	18.24B	18.98B	24.35B	19.71B	29.13B
EBITA	16.79B	17.49B	22.65B	18.02B	27.28B
EBIT	14.89B	15.86B	20.56B	15.97B	24.89B
EBITDAR	18.59B	19.32B	24.69B	20.04B	29.48B
Effective Tax Rate - (Ratio)	19.44	10.96	11.66	80.04	14.06
Current Domestic Taxes	1.02B	61M	2.32B	976M	929M
Current Foreign Taxes	1.36B	1.27B	1.16B	2.44B	3.12B
Total Current Taxes	2.38B	1.33B	3.49B	3.41B	4.05B
Deferred Domestic Taxes	-628M	264M	-1.64B	-1.67B	-1.46B
Deferred Foreign Taxes	-40M	-77M	71M	-233M	212M
Total Deferred Taxes	-668M	187M	-1.57B	-1.9B	-1.25B
Normalized Net Income	8.8B	9.39B	12.62B	9.51B	15.04B
Non-Cash Pension Expense	-207M	17M	-101M	-396M	-509M
Supplemental Operating Expense Items
Advertising Expense	2B	2B	2.2B	2.3B	2.4B
Selling and Marketing Expenses	2B	2B	2.2B	2.3B	2.4B
Research And Development Expense From Footnotes	13.56B	12.24B	13.55B	30.53B	17.94B
Net Rental Expense, Total	346M	343M	334M	339M	348M
Imputed Operating Lease Interest Expense	75.66M	65M	77.17M	91.07M	94.94M
Imputed Operating Lease Depreciation	270M	278M	257M	248M	253M
Stock-Based Comp., Other (Total)	475M	479M	541M	645M	761M
Total Stock-Based Compensation	475M	479M	541M	645M	761M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	8.06B	8.1B	12.69B	6.84B	13.24B
Short Term Investments	-	-	498M	252M	447M
Trading Asset Securities, Total	1M	14M	-	-	-
Total Cash And Short Term Investments	8.06B	8.11B	13.19B	7.09B	13.69B
Accounts Receivable, Total	8.29B	10.78B	10.62B	11.7B	11.12B
Other Receivables	-	-	-	-	8M
Total Receivables	8.29B	10.78B	10.62B	11.7B	11.13B
Inventory	6.31B	5.95B	5.91B	6.36B	6.11B
Restricted Cash	-	-	79M	68M	76M
Other Current Assets, Total	5.1B	5.42B	5.92B	6.94B	7.78B
Total Current Assets	27.76B	30.27B	35.72B	32.17B	38.78B
Gross Property Plant And Equipment	38.69B	39.06B	40.75B	42.75B	44.3B
Accumulated Depreciation	-18.98B	-18.19B	-17.98B	-18.27B	-19.16B
Net Property Plant And Equipment	19.71B	20.86B	22.77B	24.49B	25.15B
Long-term Investments	1.42B	966M	1.85B	1.56B	1.61B
Goodwill	20.24B	21.26B	21.2B	21.2B	21.67B
Other Intangibles, Total	14.6B	22.93B	20.27B	18.01B	16.37B
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	894M	692M	503M	1.97B	3.6B
Other Long-Term Assets, Total	6.95B	8.71B	6.85B	7.28B	9.93B
Total Assets	91.59B	106B	109B	107B	117B
Liabilities
Accounts Payable, Total	5.02B	6.39B	5.04B	4.97B	5B
Accrued Expenses, Total	11.44B	11.49B	12.63B	14.19B	13.87B
Short-term Borrowings	4.13B	112M	246M	72M	149M
Current Portion of Long-Term Debt	2.3B	2.3B	1.7B	1.3B	2.5B
Current Portion of Leases	300M	304M	281M	285M	282M
Current Income Taxes Payable	1.58B	1.22B	1.99B	2.65B	3.91B
Other Current Liabilities	2.57B	2.05B	2.36B	2.23B	2.71B
Total Current Liabilities	27.33B	23.87B	24.24B	25.69B	28.42B
Long-Term Debt	25.36B	30.69B	28.74B	33.68B	34.46B
Long-Term Leases	1.36B	1.22B	1.01B	928M	877M
Pension & Other Post Retirement Benefits	3.65B	1.87B	1.22B	1.23B	939M
Deferred Tax Liability Non Current	1.02B	3.44B	1.8B	871M	1.39B
Other Non Current Liabilities	7.47B	6.34B	6.09B	6.63B	4.65B
Total Liabilities	66.18B	67.44B	63.1B	69.04B	70.73B
Common Stock, Total	1.79B	1.79B	1.79B	1.79B	1.79B
Additional Paid In Capital	39.59B	44.24B	44.38B	44.51B	44.7B
Retained Earnings	47.36B	53.7B	61.08B	53.9B	63.07B
Treasury Stock	-56.79B	-57.11B	-56.49B	-57.45B	-58.3B
Comprehensive Income and Other	-6.63B	-4.43B	-4.77B	-5.16B	-4.94B
Total Common Equity	25.32B	38.18B	45.99B	37.58B	46.31B
Minority Interest	87M	73M	67M	54M	59M
Total Equity	25.4B	38.26B	46.06B	37.64B	46.37B
Total Liabilities And Equity	91.59B	106B	109B	107B	117B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.53B	2.53B	2.54B	2.53B	2.53B
ECS Total Common Shares Outstanding	2.53B	2.53B	2.54B	2.53B	2.53B
Book Value / Share	10.01	15.11	18.12	14.84	18.32
Tangible Book Value	-9.52B	-6.01B	4.52B	-1.63B	8.28B
Tangible Book Value Per Share	-3.76	-2.38	1.78	-0.64	3.27
Total Debt	33.45B	34.63B	31.98B	36.27B	38.27B
Net Debt	25.39B	26.52B	18.79B	29.18B	24.58B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.43B	312M	42M	122M	-939M
Debt Equivalent Oper. Leases	2.77B	2.74B	2.67B	2.71B	2.78B
Minority Interest, Total (Incl. Fin. Div)	87M	73M	67M	54M	59M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	-82M	-16M	-293M	-562M	-840M
Inventories - Raw Materials, Total	4.22B	4.03B	4.12B	4.69B	4.64B
Inventories - Finished Goods, Total	1.96B	1.75B	1.84B	1.95B	2.02B
Inventories - Others	206M	196M	238M	277M	289M
Land - (BS)	350M	326M	295M	326M	307M
Buildings, Total	12.64B	12.53B	13.17B	14.97B	16.36B
Machinery, Total	16.65B	16.3B	16.76B	17.76B	18.28B
Full Time Employees	73K	67K	67K	70K	73K
Part Time Employees	1K	1K	2K	2K	2K
Accumulated Allowance for Doubtful Accounts (Supple)	85M	62M	72M	88M	89M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	7.07B	13.05B	14.52B	365M	17.12B
Depreciation & Amortization - CF	1.46B	1.49B	1.7B	1.69B	1.85B
Amortization of Goodwill and Intangible Assets - (CF)	1.9B	1.64B	2.08B	2.04B	2.4B
Depreciation & Amortization, Total	3.36B	3.12B	3.79B	3.73B	4.24B
Asset Writedown & Restructuring Costs	1.99B	393M	1.87B	932M	293M
(Income) Loss On Equity Investments - (CF)	-	-1.94B	1.42B	-340M	-14M
Stock-Based Compensation (CF)	475M	479M	541M	645M	761M
Net Cash From Discontinued Operations	-	987M	-	-	-
Other Operating Activities, Total	1.96B	1.86B	-260M	9.88B	2.73B
Change In Accounts Receivable	-1B	-2.03B	-644M	-1.15B	-244M
Change In Inventories	-855M	-674M	-161M	-816M	-835M
Change In Accounts Payable	724M	405M	-289M	-380M	182M
Change In Income Taxes	560M	-540M	380M	214M	1.02B
Change in Other Net Operating Assets	-4.02B	-997M	-2.07B	-75M	-3.79B
Cash from Operations	10.25B	14.11B	19.1B	13.01B	21.47B
Capital Expenditure	-4.68B	-4.45B	-4.39B	-3.86B	-3.37B
Cash Acquisitions	-6.61B	-12.91B	-121M	-12.03B	-4.09B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	1.72B	1.02B	-483M	1.85B	-142M
Other Investing Activities, Total	130M	-225M	32M	-36M	-127M
Cash from Investing	-9.44B	-16.56B	-4.96B	-14.08B	-7.73B
Short Term Debt Issued, Total	2.55B	-	-	-	-
Long-Term Debt Issued, Total	4.42B	7.94B	-	5.94B	3.6B
Total Debt Issued	6.97B	7.94B	-	5.94B	3.6B
Short Term Debt Repaid, Total	-	-3.99B	-	-	-
Long-Term Debt Repaid, Total	-1.96B	-2.32B	-2.25B	-1.76B	-1.29B
Total Debt Repaid	-1.96B	-6.3B	-2.25B	-1.76B	-1.29B
Issuance of Common Stock	89M	202M	384M	125M	177M
Repurchase of Common Stock	-1.28B	-840M	-	-1.35B	-1.31B
Common Dividends Paid	-6.22B	-6.61B	-7.01B	-7.44B	-7.84B
Common & Preferred Stock Dividends Paid	-6.22B	-6.61B	-7.01B	-7.44B	-7.84B
Other Financing Activities, Total	-436M	8.21B	-240M	-328M	-372M
Cash from Financing	-2.83B	2.59B	-9.12B	-4.81B	-7.03B
Foreign Exchange Rate Adjustments	253M	-133M	-410M	23M	-293M
Net Change in Cash	-1.77B	14M	4.61B	-5.86B	6.41B
Supplemental Items
Cash Interest Paid	822M	779M	937M	1.1B	1.3B
Cash Income Tax Paid (Refund)	2.7B	2.4B	3.2B	4.34B	3.93B
Levered Free Cash Flow	7.49B	6.67B	12.69B	9.26B	17.83B
Unlevered Free Cash Flow	8.01B	7.17B	13.29B	9.98B	18.62B
Change In Net Working Capital	445M	1.89B	-496M	520M	-1.43B
Net Debt Issued / Repaid	5.01B	1.63B	-2.25B	4.18B	2.31B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	10.57	10.05	11.96	9.25	13.9
Return on Total Capital	16.58	15.05	17.03	13.14	19.62
Return On Equity %	27.55	38.82	34.46	0.9	40.79
Return on Common Equity	27.59	38.88	34.5	0.87	40.81
Margin Analysis
Gross Profit Margin %	72.03	72.81	70.98	73.53	77.09
SG&A Margin	19.53	19.31	16.31	16.44	15.74
EBITDA Margin %	38.01	38.97	41.08	32.78	45.4
EBITA Margin %	34.98	35.92	38.21	29.97	42.52
EBIT Margin %	31.02	32.56	34.69	26.57	38.79
Income From Continuing Operations Margin %	14.76	25.37	24.5	0.63	26.7
Net Income Margin %	14.72	26.79	24.49	0.61	26.68
Net Avail. For Common Margin %	14.72	25.35	24.49	0.61	26.68
Normalized Net Income Margin	18.33	19.28	21.29	15.83	23.44
Levered Free Cash Flow Margin	15.6	13.69	21.41	15.41	27.79
Unlevered Free Cash Flow Margin	16.68	14.73	22.42	16.6	29.02
Asset Turnover
Asset Turnover	0.55	0.49	0.55	0.56	0.57
Fixed Assets Turnover	2.68	2.46	2.72	2.54	2.59
Receivables Turnover (Average Receivables)	6.24	5.41	5.54	5.39	5.78
Inventory Turnover (Average Inventory)	2.18	2.3	2.9	2.59	2.36
Short Term Liquidity
Current Ratio	1.02	1.27	1.47	1.25	1.36
Quick Ratio	0.6	0.79	0.98	0.73	0.87
Operating Cash Flow to Current Liabilities	0.38	0.59	0.79	0.51	0.76
Days Sales Outstanding (Average Receivables)	58.69	67.52	65.88	67.78	63.29
Days Outstanding Inventory (Average Inventory)	167.54	158.6	125.84	140.69	155.22
Average Days Payable Outstanding	124.16	147.9	121.49	112.98	119.47
Cash Conversion Cycle (Average Days)	102.07	78.22	70.23	95.49	99.04
Long Term Solvency
Total Debt/Equity	131.68	90.52	69.44	96.37	82.53
Total Debt / Total Capital	56.84	47.51	40.98	49.08	45.21
LT Debt/Equity	105.19	83.42	64.61	91.96	76.21
Long-Term Debt / Total Capital	45.4	43.79	38.13	46.83	41.75
Total Liabilities / Total Assets	72.26	63.8	57.81	64.72	60.4
EBIT / Interest Expense	17.91	19.67	21.38	13.94	19.58
EBITDA / Interest Expense	22.37	23.97	25.66	17.49	23.2
(EBITDA - Capex) / Interest Expense	16.73	18.46	21.1	14.12	20.54
Total Debt / EBITDA	1.8	1.79	1.3	1.81	1.3
Net Debt / EBITDA	1.37	1.37	0.76	1.46	0.83
Total Debt / (EBITDA - Capex)	2.41	2.33	1.58	2.24	1.47
Net Debt / (EBITDA - Capex)	1.83	1.78	0.93	1.8	0.94
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.46	17.31	21.72	1.4	6.74
Gross Profit, 1 Yr. Growth %	2.64	18.36	19.53	5.05	11.92
EBITDA, 1 Yr. Growth %	-0.7	31.26	31.13	-18.84	47.84
EBITA, 1 Yr. Growth %	-0.83	33.95	32.57	-20.19	51.43
EBIT, 1 Yr. Growth %	-0.44	41.05	33.12	-22.04	55.81
Earnings From Cont. Operations, 1 Yr. Growth %	-27.56	173.23	17.54	-97.4	4.44K
Net Income, 1 Yr. Growth %	-28.2	84.65	11.27	-97.49	4.59K
Normalized Net Income, 1 Yr. Growth %	-2.05	43.8	38.14	-24.33	58.12
Diluted EPS Before Extra, 1 Yr. Growth %	-27.03	173.03	17.49	-97.55	4.71K
Accounts Receivable, 1 Yr. Growth %	16.65	48.88	-1.47	10.2	0.42
Inventory, 1 Yr. Growth %	5.55	7.18	-0.71	7.56	-3.92
Net Property, Plant and Equip., 1 Yr. Growth %	22.23	11.65	9.12	7.55	2.7
Total Assets, 1 Yr. Growth %	8.52	15.4	3.28	-2.28	9.78
Tangible Book Value, 1 Yr. Growth %	23.48	-21.56	-175.14	-136.01	-608.6
Common Equity, 1 Yr. Growth %	-2.28	50.82	20.45	-18.29	23.24
Cash From Operations, 1 Yr. Growth %	-23.71	37.77	35.34	-31.89	65.06
Capital Expenditures, 1 Yr. Growth %	34.87	0.43	-1.35	-11.96	-12.71
Levered Free Cash Flow, 1 Yr. Growth %	-29.38	26.09	98.28	-26.75	92.51
Unlevered Free Cash Flow, 1 Yr. Growth %	-28.26	23.49	92.52	-24.66	86.65
Dividend Per Share, 1 Yr. Growth %	10.91	6.56	6.15	5.8	5.48
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.53	11.58	19.49	11.1	4.04
Gross Profit, 2 Yr. CAGR %	9.29	12.42	19.37	12	8.43
EBITDA, 2 Yr. CAGR %	11.7	17.64	33.75	7.61	9.54
EBITA, 2 Yr. CAGR %	12.75	19.1	36.19	7.72	9.94
EBIT, 2 Yr. CAGR %	21.39	22.09	40.65	7.23	10.21
Earnings From Cont. Operations, 2 Yr. CAGR %	6.94	48.47	79.21	-82.53	8.6
Net Income, 2 Yr. CAGR %	6.59	15.14	43.33	-83.28	8.58
Normalized Net Income, 2 Yr. CAGR %	20.56	22.03	45.02	7.96	9.38
Diluted EPS Before Extra, 2 Yr. CAGR %	9.47	48.29	79.11	-83.03	8.65
Accounts Receivable, 2 Yr. CAGR %	7.1	23.17	21.12	4.2	2.32
Inventory, 2 Yr. CAGR %	7.7	-0.21	3.16	3.35	1.66
Net Property, Plant and Equip., 2 Yr. CAGR %	21.78	13.75	10.38	8.33	5.1
Total Assets, 2 Yr. CAGR %	5.28	11.91	9.17	0.46	3.58
Tangible Book Value, 2 Yr. CAGR %	43.03	-11.71	-23.23	-47.98	35.34
Common Equity, 2 Yr. CAGR %	-2.63	21.4	34.78	-0.79	0.35
Cash From Operations, 2 Yr. CAGR %	-3.11	2.46	36.55	-3.99	6.03
Capital Expenditures, 2 Yr. CAGR %	33.84	14.9	-0.46	-6.81	-12.34
Levered Free Cash Flow, 2 Yr. CAGR %	-7.15	-6.57	63.29	30.63	18.75
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.54	-6.46	58.68	29.7	18.58
Dividend Per Share, 2 Yr. CAGR %	12.73	8.71	6.36	5.98	5.64
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.15	4.82	14.86	13.13	9.63
Gross Profit, 3 Yr. CAGR %	8.05	7.01	14.46	14.39	11.97
EBITDA, 3 Yr. CAGR %	13.08	9.08	21.09	13.12	19.63
EBITA, 3 Yr. CAGR %	14.44	9.83	22.46	13.84	20.67
EBIT, 3 Yr. CAGR %	23	16.22	24.57	15.4	21.45
Earnings From Cont. Operations, 3 Yr. CAGR %	43.08	25.9	37.35	-56.32	11.51
Net Income, 3 Yr. CAGR %	43.45	28.02	13.83	-62.76	9.47
Normalized Net Income, 3 Yr. CAGR %	21.79	15.78	26.02	16.61	22.6
Diluted EPS Before Extra, 3 Yr. CAGR %	47.29	27.95	37.22	-57.15	11.52
Accounts Receivable, 3 Yr. CAGR %	6.21	14.26	14.34	17.36	1.04
Inventory, 3 Yr. CAGR %	7.38	3.05	-0.38	4.61	0.87
Net Property, Plant and Equip., 3 Yr. CAGR %	16.58	16.22	12.18	9.43	6.42
Total Assets, 3 Yr. CAGR %	1.39	8.55	8.95	5.21	3.48
Tangible Book Value, 3 Yr. CAGR %	72.09	8.9	-16.33	-40.35	11.23
Common Equity, 3 Yr. CAGR %	-9.66	12.66	21.08	14.07	6.64
Cash From Operations, 3 Yr. CAGR %	16.7	8.91	12.42	8.29	15.02
Capital Expenditures, 3 Yr. CAGR %	35.37	19.37	9.21	-4.46	-8.82
Levered Free Cash Flow, 3 Yr. CAGR %	4.87	-8.43	18.43	24.85	48.66
Unlevered Free Cash Flow, 3 Yr. CAGR %	4.77	-7.86	17.48	23.64	46.43
Dividend Per Share, 3 Yr. CAGR %	9.08	10.63	7.85	6.17	5.81
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.97	4.12	8.12	7.29	10.4
Gross Profit, 5 Yr. CAGR %	6.63	6.16	8.95	8.84	12.01
EBITDA, 5 Yr. CAGR %	4.18	4.38	14.06	6.15	16.26
EBITA, 5 Yr. CAGR %	4.51	4.75	15.12	6.41	17.21
EBIT, 5 Yr. CAGR %	11.44	9.5	20.78	9.6	18.53
Earnings From Cont. Operations, 5 Yr. CAGR %	9.69	25.68	43.13	-42.87	25.04
Net Income, 5 Yr. CAGR %	9.73	27.19	43.4	-43.28	11.7
Normalized Net Income, 5 Yr. CAGR %	11.21	9.18	20.99	9.47	18.99
Diluted EPS Before Extra, 5 Yr. CAGR %	12.25	28.08	45.69	-42.97	24.98
Accounts Receivable, 5 Yr. CAGR %	4.92	8.96	8.95	10.13	9.37
Inventory, 5 Yr. CAGR %	6.07	4.11	3.01	3.17	0.43
Net Property, Plant and Equip., 5 Yr. CAGR %	9.52	11.65	12.85	13	9.29
Total Assets, 5 Yr. CAGR %	-2.07	2.08	4.43	5.24	6.77
Tangible Book Value, 5 Yr. CAGR %	16.96	5.41	19.31	-18.96	1.41
Common Equity, 5 Yr. CAGR %	-10.74	-0.97	6.02	7.08	12.32
Cash From Operations, 5 Yr. CAGR %	-3.94	6.34	24.24	3.55	9.82
Capital Expenditures, 5 Yr. CAGR %	29.56	22.48	18.37	8.12	0.02
Levered Free Cash Flow, 5 Yr. CAGR %	-8.53	-7.53	14.34	1.29	18.47
Unlevered Free Cash Flow, 5 Yr. CAGR %	-7.95	-6.97	13.8	1.71	17.83
Dividend Per Share, 5 Yr. CAGR %	6.27	7.16	7.98	8.75	6.96